Trials / Conditions / Pneumonitis, Interstitial
Pneumonitis, Interstitial
3 registered clinical trials studyying Pneumonitis, Interstitial — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia NCT04390061 | Università Politecnica delle Marche | Phase 2 |
| Recruiting | A Single-cell Approach to Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint Blockade NCT04807127 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | Rituximab in Interstitial Pneumonitis NCT02251964 | Human Adams | Phase 2 / Phase 3 |